Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 15, Number 11—November 2009

Dispatch

Travel-related Schistosomiasis Acquired in Laos

Eyal Leshem, Eyal Meltzer, Esther Marva, and Eli SchwartzComments to Author 
Author affiliations: Chaim Sheba Medical Center, Tel Hashomer, Israel (E. Leshem, E. Meltzer, E. Schwartz); Tel Aviv University Sackler School of Medicine, Ramat Aviv, Israel (E. Leshem, E. Meltzer, E. Schwartz); Ministry of Health, Jerusalem, Israel (E. Marva)

Main Article

Table 2

Clinical characteristics of patients with acute schistosomiasis acquired in Laos compared with those of case-patients from Tanzania*

Clinical characteristic Infections acquired in Laos, n = 7 Infections among case-patients in Tanzania, n = 19
Fever 6 (86) 13 (68)
Headache 6 (86)† 2 (10)
Urticaria 5 (71) 7 (37)
Cough 5 (71) 15 (78)
Fatigue 4 (57) 11 (58)
Angioedema 3 (42) 2 (10)
Abdominal pain 3 (42) 5 (26)
Diarrhea 2 (28) 7 (37)
Myalgia 2 (28) 7 (37)
Cercarial dermatitis 1 (14) 3 (16)
Time from exposure to seeking medical care, d (±SD) 27 (±4) 38 (±22)
Eosinophil count, cells/mm (±SD) 3,595 (±3,218) 3,535 
(±2,394)

*Patients with cases suspected to be caused by Schistosoma mekongi infection compared with patients infected with S. mansoni and/or S. haematobium in Tanzania (7). All values are no. (%) except as indicated.
†p<0.001.

Main Article

TOP